Equities

GoodRx Holdings Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
GDRX:NSQ

GoodRx Holdings Inc

Actions
Health CareHealth Care Providers
  • Price (USD)2.36
  • Today's Change-0.02 / -0.84%
  • Shares traded2.01m
  • 1 Year change-54.00%
  • Beta1.4852
Data delayed at least 15 minutes, as of Feb 19 2026 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
ASSETS
Cash And Short Term Investments448672757
Total Receivables, Net161160122
Total Inventory------
Prepaid expenses504041
Other current assets, total------
Total current assets659873920
Property, plant & equipment, net404656
Goodwill, net411411412
Intangibles, net177156190
Long term investments------
Note receivable - long term------
Other long term assets243827
Total assets1,3881,5891,605
LIABILITIES
Accounts payable143618
Accrued expenses817044
Notes payable/short-term debt000
Current portion long-term debt/capital leases5.008.797.03
Other current liabilities, total237.117.88
Total current liabilities12412376
Total long term debt487648652
Total debt492656659
Deferred income tax------
Minority interest------
Other liabilities, total535762
Total liabilities663827790
SHAREHOLDERS EQUITY
Common stock0.040.040.04
Additional paid-in capital2,1662,2192,263
Retained earnings (accumulated deficit)(1441)(1457)(1449)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity725762815
Total liabilities & shareholders' equity1,3881,5891,605
Total common shares outstanding383394397
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.